Navya Pharma Private Limited
About Navya Pharma Private Limited
Data last updated:
Navya Pharma Private Limited is a private limited company based in New, Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 09 September 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2013PTC257435. Its GSTIN is 20AAECN4527E1ZZ (Jharkhand).
The company has an authorised share capital of ₹4 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors including Vinay Kumar and Niraj Nath.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Z – 37 Commercial Enclave, Mohan Garden, New, Delhi, India – 110059.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.77 Cr, a decline of 30% compared to the previous year. For the same year it recorded a net profit of ₹6.55 Lakh (net margin 3.7%) and EBITDA of ₹9.54 Lakh (EBITDA margin 5.4%). Revenue has declined at a compounded annual rate (CAGR) of 15% over three years and 3% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressZ – 37 Commercial Enclave, Mohan Garden, New, Delhi, India – 110059
- IndustryTrading, Other Wholesale, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Navya Pharma Private Limited
The main business activity of Navya Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Navya Pharma Private Limited
Navya Pharma Private Limited is audited by A. K. Kejariwal & Associates for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| A. K. Kejariwal & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Navya Pharma Private Limited
Navya Pharma has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vinay Kumar | Director | 09 Sep 2013 | 13 Years 0 Months | Current |
| Niraj Nath Also directs: Vinima Pharma Private Limited | Director | 09 Sep 2013 | 13 Years 0 Months | Current |
| Vikesh Nath | Director | 29 Apr 2025 | 1 Years 5 Months | Current |
| Manish Nath | Director | 29 Apr 2025 | 1 Years 5 Months | Current |
Financials of Navya Pharma Private Limited FY 2025 filings available
Navya Pharma Private Limited reported revenue of ₹1.77 Cr (down 30% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Navya Pharma Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 30% fall in the latest year. EBITDA fell 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Navya Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹9.54 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹6.55 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Navya Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Navya Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Navya Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Navya Pharma Private Limited
Navya Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Navya Pharma Private Limited
Employment history and EPFO contributions of people linked to Navya Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Navya Pharma Private Limited
Navya Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 20AAECN4527E1ZZ | Jharkhand | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Navya Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Navya Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Navya Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Navya Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Navya Pharma Private Limited
Frequently Asked Questions about Navya Pharma Private Limited
Navya Pharma is an active private limited company based in New, Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 09 September 2013 (13+ years old) and is registered under CIN U74999DL2013PTC257435.
Navya Pharma reported revenue of ₹1.77 Cr for FY 2025 (down 30% YoY).
Navya Pharma has 4 current directors:
- Vinay Kumar - Director
- Niraj Nath - Director
- Vikesh Nath - Director
- Manish Nath - Director
Navya Pharma reported a net profit of ₹6.55 Lakh (net margin 3.7%) and EBITDA of ₹9.54 Lakh (EBITDA margin 5.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Navya Pharma is -15% over three years and -3% over five years. In the latest year (FY 2025) revenue fell 30%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Navya Pharma is 20AAECN4527E1ZZ, registered in Jharkhand.
The CIN (Corporate Identification Number) of Navya Pharma is U74999DL2013PTC257435. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Navya Pharma was incorporated on 09 September 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
The registered office of Navya Pharma is at Z – 37 Commercial Enclave, Mohan Garden, New, Delhi, India – 110059.